Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
The Speedel Group, based in Basel, Switzerland, is a biopharmaceutical company with a core competence in drug development, focusing on early proof-of-concept in man in cardiovascular and metabolic diseases. These are the main causes of death in the industrialized world and represent the largest pharmaceutical market segments worldwide. A privately owned company formed in 1998, Speedel employs a team of over forty experienced pharmaceutical scientists and managers in Europe, the United States and Japan. Speedel in-licenses innovative drug candidates at late preclinical or early clinical development stages and upon completion of proof-of-concept in man at Phase II, Speedel partners with leading pharmaceutical companies for Phase III development and ( www.speedel.com )
Speedel Pharmaceuticals Inc
1661 Route 22 West P.O. Box 6532
Bridgewater, New Jersey 08807
USA
Tel: (732) 537-2290
Fax: (732) 537-2292